Veterinary Active Pharmaceutical Ingredients Manufacturing Market: In-House Service Type Segment Is Estimated To Register The Fastest CAGR

 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Overview

The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.4 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.9% over the forecast period. The increasing prevalence of chronic diseases in animals and growing concerns among pet owners are the key contributors to the market growth.

 

Moreover, the growing prevalence of zoonotic diseases is driving the demand for drugs, which, in turn, boosts the demand for active pharmaceutical ingredients (APIs) for the production of these drugs. According to the Centers for Disease Control and Prevention (CDC), in July 2017, it was estimated that 6 out of 10 known infectious diseases in people can be transmitted from animals and 3 out of every 4 novel or emerging infectious diseases in people are caused due to animals.

Government organizations are involved in issuing various guidelines to promote veterinary services globally, which is expected to contribute to market growth in the coming years. For instance, in May 2018, the OIE International Standards, a part of the WTO framework, issued standards to improve animal health, which will affect human health as well. One of the key challenges was found to be the lack of technical expertise in this field.

The rising number of veterinarians is also anticipated to boost the market growth. According to the American Veterinary Medical Association, in 2018, there were 113,394 veterinarians in the U.S. as compared to 110,531 veterinarians in 2017. Out of these, 48,898 were involved in private clinical practice exclusively for companion animals. Also, according to the Canadian Veterinary Medical Association (CVMA), the approximate number of veterinarians in Canada is 12,921.

 

Veterinary API Manufacturing Market Segmentation

Grand View Research has segmented the global veterinary active pharmaceutical ingredients manufacturing market on the basis of service type, synthesis type, product, and region:

Based on the Type Insights, the market is segmented into In House, and Contract Outsourcing.

  • The contract outsourcing service type accounted for the largest revenue share of over 58% in 2020 owing to the associated benefits with its adoption. Companies are outsourcing raw material procurement and manufacturing services. 

 

  • The in-house service type segment is estimated to register the fastest CAGR over the forecast period as this service type ensures complete control over the process and intellectual property associated with the therapy. This service type is especially popular among early-stage companies with innovative manufacturing processes or therapies that are developed by research staff or founders in the laboratory.

 

Based on the Synthesis Type Insights, the market is segmented into Chemical-based API, Biological API, and HPAPI.

  • The chemical-based API segment dominated the global veterinary API manufacturing market with a revenue share of over 39% in 2020. This can be attributed to the high usage of these APIs by many major manufacturing companies. Also, according to Lonza, around 70 to 80% of the drugs in the market are chemical-based.

 

  • The HPAPI segment is projected to register the fastest CAGR from 2021 to 2028. High-potency APIs have a dosage rate of 20 to 50 times lower than the typical APIs, which boosts their demand. Favorable government regulations for R&D and commercialization of novel drug molecules are also anticipated to drive the segment. 

 

Based on the Product Insights, the market is segmented into Antiparasitic, Anti-infectives, NSAIDs, Vaccines, Biologics, and Others.

  • The vaccines product segment held the largest market share of over 23% in 2020 and will expand further at a significant CAGR from 2021 to 2028. This growth can be attributed to the rising demand for vaccinesdue to the high prevalence of chronic diseases in animals.

 

  • NSAIDs are expected to be the fastest-growing segment over the forecast period. The anti-infectives products segment is estimated to account for the second-highest revenue share by 2028 due to increasing incidences of infections in animals. 

 

Veterinary API Manufacturing Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Key Companies Profile & Market Share Insights

Major companies are focusing on strategic initiatives like acquisitions and mergers to maintain their dominance in the market. For instance, in November 2020, Alivira Animal Health Ltd. acquired Provet Veteriner Urunleri San. Ve Tic. A. S. in Turkey. This furthered the company’s geographical footprint and product lineup. In October 2019, SUANFARMA acquired an API manufacturing plant in Italy called Sandoz Industrial Products SpA. This expanded the company’s production capacity and supported its global expansion strategy. Some of the key companies in the global veterinary API manufacturing market are:

  • Alivira Animal Health Ltd.
  • Excel Industries Ltd.
  • Ofichem Group
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Menadiona
  • Afton Pharma
  • Jiangsu Lingyun Pharmaceutical Co., Ltd.
  • SUANFARMA
  • NGL Fine-Chem Ltd.
  • FIS - Fabbrica Italiana Sintetici S.p.A

 

Order a free sample PDF of the Veterinary API Manufacturing Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Breast Pump and Breastfeeding Accessories Market Updates and Projections

  Breast Pump And Breastfeeding Accessories Industry Data Book | Forecast 2030 Breast Pump And Breastfeeding Accessories Industry Data Book - Breast Pump, Wearable Breast Pump & Breastfeeding Accessories Market Grand View Research’s breast pump & breastfeeding accessories industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.   Access the Global Breast Pump And Breastfeeding Accessories Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory ...
Read more

Spectrometry Sector: Emerging Technologies 2023-2030

  Spectrometry Industry | Forecast 2030 Spectrometry industry data book is a combination of the market data from five reports namely, spectrometry, mass spectrometry, NMR spectroscopy, near-infrared spectroscopy, and in-line UV-vis spectroscopy market. The market was valued at USD 17.4 billion in 2021 with a CAGR of 7.34% during 2022-2030. NMR spectroscopy market and Near-infrared Spectroscopy market are also growing at the CAGR of 5.1% and 6.08% respectively. The development of advanced spectrometry instruments and consumables is anticipated to create growth opportunities in this market and drive the market in the coming years.   Access the Global Spectrometry Industry Data Book, 2024 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies   Spectrometry holds significant potential in the near future o...
Read more

Endoscopy Devices Market Predicted to Witness Strong Growth from 2023 to 2030

  Endoscopy Devices Industry | Forecast 2030 The global endoscopy devices market was valued at USD 50.8 Billion in 2022 and is anticipated to grow at a CAGR of 7.5% over the forecast period. The market growth is attributed to the presence of cost-effective pre and post-procedures and increasing awareness regarding the minimal invasive properties of the devices. COVID-19 has impacted the market negatively as the number of endoscopic procedures reduced owing to the postponed and canceled elective and semi-urgent procedures. However, the increasing geriatric population, coupled with the rising burden of chronic diseases, is anticipated to drive the market. Furthermore, increasing the preference for disposable endoscopic equipment reduce the possibility of cross-contamination is anticipated to drive the market over the forecast period.   Access the Global Endoscopy Devices Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, ...
Read more